MS-AnergiX peptide epitope of the suspected multiple sclerosis antigen combined with soluble major histocompatibility complex: Will begin a Phase I/II trial in

Anergen Inc. (ANRG), Redwood City, Calif. Product: MS-AnergiX peptide epitope of the suspected multiple sclerosis antigen combined with soluble major histocompatibility complex Indication: Multiple sc...